Xylem
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $2,169,000 | $2,033,000 | $2,119,000 |
Gross Profit | 818,000 | 753,000 | 759,000 |
EBITDA | 420,000 | 354,000 | 370,000 |
EBIT | 275,000 | 220,000 | 233,000 |
Net Income | 194,000 | 153,000 | 266,000 |
Net Change In Cash | 2,169,000 | 2,033,000 | 2,119,000 |
Free Cash Flow | 215,000 | 15,000 | 361,000 |
Cash | 815,000 | 947,000 | 1,019,000 |
Basic Shares | 243,538 | 243,021 | 241,504 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7,367,000 | $5,522,000 | $5,195,000 | $4,876,000 |
Gross Profit | 2,724,000 | 2,084,000 | 1,975,000 | 1,830,000 |
EBITDA | 1,171,000 | 754,000 | 837,000 | 746,000 |
EBIT | 735,000 | 518,000 | 592,000 | 495,000 |
Net Income | 609,000 | 355,000 | 427,000 | 254,000 |
Net Change In Cash | 7,367,000 | 5,522,000 | 5,195,000 | 4,876,000 |
Cost of Revenue | -385,000 | -526,000 | 1,151,000 | |
Free Cash Flow | 566,000 | 388,000 | 330,000 | 641,000 |
Cash | 1,019,000 | 944,000 | 1,349,000 | 1,875,000 |
Basic Shares | 218,180 | 180,979 | 181,526 | 181,099 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $1.11 |
2024-06-30 | $1.09 |
2024-03-31 | $0.90 |
2023-12-31 | $0.99 |
